Clinical Pearls for Community-based Oncologists Treating Patients with BRAF-mutated Metastatic Melanoma: Incorporating Novel Sequencing Strategies into Practice

Clinical Pearls for Community-based Oncologists Treating Patients with BRAF-mutated Metastatic Melanoma: Incorporating Novel Sequencing Strategies into Practice is organized by Med Learning Group.

Smart Reach Replay:
This enduring TeleECHO program will explore key clinical practice insights for management of patients with BRAF-mutated metastatic melanoma. Over the course of this activity there will be discussion of the clinical profiles of frontline combination immuno- and targeted treatment options in BRAF-mutated metastatic melanoma as well as emerging data from clinical trials and real-world studies examining sequencing of these therapies. Interactive case studies will illustrate strategies for treatment selection, mitigation of adverse events, and management considerations for patients with BRAF-mutated metastatic melanoma.

Educational Objective:
Upon the completion of this program, attendees should be able to:

• Identify the AEs associated with frontline combination immuno- and targeted treatment options for BRAF-mutated metastatic melanoma in order to mitigate them should they arise

Episode #1: First-Line and Novel Sequencing of Immuno- and Targeted Therapy Combinations in Metastatic Melanoma
This Community Oncology Connection SmartCast^TM Micro-Learning Podcast Series will explore key clinical practice insights for management of patients with BRAF-mutated metastatic melanoma. Over the course of three episodes there will be discussion of the clinical profiles of frontline combination immuno- and targeted treatment options in BRAF-mutated metastatic melanoma as well as emerging data from clinical trials and real-world studies examining sequencing of these therapies. Case studies will illustrate strategies for treatment selection, mitigation of adverse events, and management considerations for patients with BRAF-mutated metastatic melanoma.

Educational Objective:
Upon the completion of this program, attendees should be able to:

• Assess the clinical profiles of frontline combination immuno- and targeted treatment options used for the management of BRAF-mutated metastatic melanoma
  Evaluate data from clinical trials and real-world studies examining the effects of sequencing frontline combination immuno- and targeted treatment options for the management of BRAF-mutant metastatic melanoma

Episode #2: Immuno- and Targeted Therapy Combinations in The Adjuvant and Neoadjuvant Setting for Metastatic Melanoma
This Community Oncology Connection SmartCast^TM Micro-Learning Podcast Series will explore key clinical practice insights for management of patients with BRAF-mutated metastatic melanoma. Over the course of three episodes there will be discussion of the clinical profiles of frontline combination immuno- and targeted treatment options in BRAF-mutated metastatic melanoma as well as emerging data from clinical trials and real-world studies examining sequencing of these therapies. Case studies will illustrate strategies for treatment selection, mitigation of adverse events, and management considerations for patients with BRAF-mutated metastatic melanoma.

Educational Objective:
Upon the completion of this program, attendees should be able to:

• Evaluate data from clinical trials and real-world studies examining the effects of sequencing frontline combination immuno- and targeted treatment options for the management of BRAF-mutant metastatic melanoma

Episode #3: Multidisciplinary Approaches to irAEs
This Community Oncology Connection SmartCast^TM Micro-Learning Podcast Series will explore key clinical practice insights for management of patients with BRAF-mutated metastatic melanoma. Over the course of three episodes there will be discussion of the clinical profiles of frontline combination immuno- and targeted treatment options in BRAF-mutated metastatic melanoma as well as emerging data from clinical trials and real-world studies examining sequencing of these therapies. Case studies will illustrate strategies for treatment selection, mitigation of adverse events, and management considerations for patients with BRAF-mutated metastatic melanoma.

Educational Objective:
Upon the completion of this program, attendees should be able to:

• Identify the AEs associated with frontline combination immuno- and targeted treatment options for BRAF-mutated metastatic melanoma in order to mitigate them should they arise.